Alantra PE, through its dental laboratory platform Aivoriq, has acquired two additional dental laboratories, further consolidating one of the leading dental laboratory groups in Spain.
The acquisitions reinforce Aivoriq’s’s footprint and strengthen its capabilities in fixed prosthetics, aesthetic treatments, and orthodontics. It is another step in the group’s progressing with its buy-and-build strategy in Spain, and also lays the foundations for future international expansion.
“The evolution of Aivoriq demonstrates the strength of our buy-and-build strategy in a fragmented and resilient healthcare market,” said Ángel Manotas, managing director of Alantra. “The platform has achieved significant scale, continues to grow above the market, and is increasingly well positioned for its next phase of development, both in Spain and internationally.”
Since Alantra PE’s initial investment in 2024, Aivoriq has grown into a nationwide platform with more than 20 dental laboratories across Spain and close to €40m in revenues. The group plans to continue its expansion in Spain (targeting around 30 laboratories) and is also exploring opportunities in European markets such as the UK, Germany, and Italy. The company is also advancing industrial and technological initiatives to enhance productivity, service quality, and scalability.
As part of the transaction, the owners of the laboratories have reinvested
Alantra PE was advised by EY Abogados.
